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Abstract 
Objective: To characterize the differences between the primary and metastatic melanoma cell lines grown in 2D 
cultures and 3D cultures.
Methods: Primary melanoma cells (WM115) and metastatic melanoma cells (WM266) extracted from a single donor 
was cultured in 2D as well as 3D cultures. These cells were characterized using proton NMR spectrometry, and the 
qualitative chemical shifts markers were identified and discussed.
Results: In monolayer culture (2D), we observed one qualitative chemical shift marker for primary melanoma cells. In 
spheroid cultures (3D), we observed nine significant chemical shifts, of which eight markers were specific for primary 
melanoma spheroids, whereas the other one marker was specific to metastatic melanoma spheroids. This study 
suggests that the glucose accumulation and phospholipid composition vary significantly between the primary and 
metastatic cells lines that are obtained from a single donor and also with the cell culturing methods. 14 qualitative 
chemical shift markers were obtained in the comparison between monolayer culture and spheroids cultures irrespec‑
tive of the differences in the cell lines. Among which 4 were unique to monolayer cultures whereas 10 chemical shifts 
were unique to the spheroid cultures. This study also shows that the method of cell culture would drastically affect 
the phospholipid composition of the cells and also depicts that the cells in spheroid culture closely resembles the 
cells in vivo.
Conclusion: This study shows the high specificity of proton NMR spectrometry in characterizing cancer cell lines 
and also shows the variations in the glucose accumulation and phospholipid composition between the primary and 
metastatic melanoma cell lines from the same donor. Differences in the cell culture method does plays an important 
role in phospholipid composition of the cells.
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Background
14.1 million new cancer cases are reported every year 
with 8.2 million annual deaths [1]. As cancer is very het-
erogeneous, it is indispensable to have better characteri-
zation procedure for its diagnosis and treatment. One 
non-destructive way of characterizing cancer cells is by 
employing nuclear magnetic resonance. In this study, 
we intend to access the specificity of the proton NMR 
method using the two closely associated melanoma cell 
lines. Cancer cells contain higher levels of phospholipids 
than normal cells, which is responsible for enhanced cell 
proliferation and signal transduction. The alteration of 
phospholipid composition aids the cancer cells in inva-
sion, metastasis and expression of growth factor recep-
tors [2, 3]. Past studies concluded that 1H MRS could be 
used to diagnose cancer and also to monitor treatment 
responses [4–7]. It had been reported in gene expres-
sion studies that 576 genes were differentially expressed 
between primary melanoma and metastatic melanoma 
among which most of the genes showed decreased 
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expression in metastatic melanoma when compared to 
primary melanoma [8]. These genes were found to be 
involved in cell adhesion, tumor suppression, cell cycle 
regulation and apoptosis. It is noteworthy that two pro-
teins namely MAGEC1 (Melanoma antigen family c1) 
and FCRL1 (Fc receptor-like 1), which were known for 
melanoma progression were up-regulated in metastatic 
melanoma [8]. Another study showed that in primary 
melanoma SPRR1A/B, KRT16/17, CD24, LOR, GATA3, 
MUC15, and TMPRSS4 were up-regulated whereas, 
MAGE, GPR19, BCL2A1, MMP14, SOX5, BUB1, RGS20 
were up-regulated in metastatic melanoma [9].
Coherent anti-Stokes Raman Scattering imaging 
revealed that free fatty acids (FFA) induced lipid accu-
mulation in the cancer cells. FFA accumulation could 
adversely affect the cell–cell contact and promotes tis-
sue invasion and positively correlated with the extend 
of metastasis [10]. Inhibition of the lipogenesis either 
by pharmacological drugs or using antisense shRNA 
resulted in the inhibition of tumor growth and metastasis 
after anti-angiogenic treatment [11, 12].
The higher levels of the choline related compounds 
were not only due to the biosynthetic pathways but also 
due to oncogene-induced activation of phosphatidyl 
choline and phosphatidyl ethanolamine-specific phos-
pholipases. This resulted in the accumulation of choline 
related compounds in tumorous or actively proliferat-
ing cells [13]. Differences in the concentration of cho-
line-containing compounds could be considered as an 
indicator for accessing the clinical response of cancer 
to chemotherapy. The outcome of the chemotherapy 
could be considered as positive if the choline-contain-
ing compounds decrease after the chemotherapy [14]. 
It is reported that metastatic melanoma of lymph node 
can be detected using proton NMR spectroscopy with a 
sensitivity of 92.9% and specificity of 90.3% [15]. Chemi-
cal shifts of choline could alone separate the melanoma 
biopsies from non-melanoma biopsy with an accuracy of 
69% [16]. Another study reported elevated levels of cho-
line, taurine, lactate and amino acids like alanine, lysine, 
glutamine and glutamate in biopsies could be potential 
biomarkers for the identification of both primary and 
secondary melanoma cells [17]. From these studies, it is 
evident that proton NMR spectroscopy is capable enough 
in discriminating melanoma cells from non-melanoma 
cells.
The biomarkers identified by the MRI coupled with 1H-
MRS and proton nuclear magnetic resonance spectrome-
try (1H-NMR) could be correlated, as both these methods 
evolve from the same principle where the former was the 
addition of imaging to the later [18]. In a recent study, 
proton nuclear magnetic resonance spectrometry identi-
fies a unique chemical shift biomarker 1.28 ppm for the 
identification of the neural stem and progenitor cells 
(NPC). This method was used to identify the NPC in the 
live mouse using the same biomarker under proton mag-
netic resonance spectroscopy (1H-MRS) [19]. From the 
previous studies, it is clear that magnetic resonance can 
be employed for cancer diagnosis using the lipid signals, 
but the specificity of the magnetic resonance method in 
detecting cancerous tissues is still not well established.
We hypothesize that the proton NMR method has 
high specificity and capable of distinguishing biologi-
cally related cell lines. To test this hypothesis, we explore 
the specificity of proton NMR method by characterizing 
the primary and metastatic melanoma cells that were 
extracted from a single donor. The specimens we selected 
for this study were WM115 (primary melanoma) and 
WM266 (metastatic melanoma) cell lines. These cells are 
closely related as they are excised from the same donor 
and vary only in the stages of cancer. We also explored 
the differences in these cells grown as adherent cells and 
as multi-cellular tumor spheroids using proton NMR. If 
our hypothesis is correct, then it is evident that proton 




WM-115 (human primary melanoma) and WM-266 
(human metastatic melanoma) cells were purchased 
from American Type Culture Collection (ATCC), USA. 
These cells were cultured in eagle’s modified essential 
medium (EMEM) with 10% fetal bovine serum (FBS). For 
the comparison of different cell lines in vitro by nuclear 
magnetic resonance (NMR), it is necessary that the cells 
should have the same histologic origin and same growth 
medium [3]. All the experiments were carried out in trip-
licates for both the cell lines.
Extraction of the intact cells
The cells were cultured until they reached 90–95% con-
fluence. The cells were washed twice with DPBS and 
harvested by trypsinization. The viability of the cells was 
checked by hemocytometer using bromophenol blue dye 
exclusion as a criterion for distinguishing live and dead 
cells. The samples with over 95% of viable cells were 
assumed to be suitable for the NMR spectrometry. The 
cells were diluted so that each sample has 1 × 107 cells.
Formation of cellular spheroids
For the spheroids formation, the cells were grown under 
2D culture condition and harvested using trypsiniza-
tion. The harvested cells were checked for viability as 
described above. These cells were diluted into 2.5 × 106 
cells/mL and each sample is an aliquot of 4 mL containing 
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1 ×  107 cells. The diluted cell samples were drawn into 
20 μL droplets on the lid of the petri dish. The petri dish 
was filled with 10  mL of DPBS which forms the hydra-
tion chamber. The petri dish lid was gently inverted and 
placed in the incubator for the spheroid formation. The 
petri dish was then incubated for 3 days. After 3 days, the 
spheroids could be observed by the naked eye as white 
spheres. The spheroids were harvested and 600  μL of 
D2O was poured gently on the harvested spheroids and 
carefully poured into the NMR tubes (Fig. 1).
Nuclear magnetic resonance (NMR) spectrometry
We performed one-dimensional 1H NMR spectrom-
etry (DRX500, Bruker USA) on the collected samples 
and matched controls using deuterated water (D2O) as 
the proton NMR solvent (Additional file  1: Figure S1). 
The acquired proton NMR spectral data was Fourier-
transformed followed by phase and baseline correction 
using the Bruker XWinNMR software version 3.5. All the 
spectrums were aligned using the Mnova 11 (Mestrelab 
Research, Spain) software. The visible peaks were manu-
ally picked and peak lists were extracted for the metab-
olite identification. The peak list was given as input to 
the Metaboanalyst 3.0 online statistical software (http://
www.metaboanalyst.ca/, Canada) for statistical analysis 
[20].
Results
NMR spectrum of the melanoma cells from monolayer 
culture and spheroid culture
The peaks were binned together by the moving window 
of 0.03 ppm and a step of 0.015 ppm, which results in a 
group of 131 chemical shifts. The binned data was then 
normalized using generalized log transformation and 
auto scaling.
Chemical shift markers identified using proton NMR 
analysis
One-way ANOVA was performed for the identification 
of the statistically significant chemical shifts (p  <  0.05). 
Among the significant chemical shifts (p  <  0.05) mark-
ers, we focus only on the qualitative markers as they are 
more relevant for the clinical translation of this study. In 
the monolayer culture, the 1H NMR spectrums of the pri-
mary and metastatic melanoma cells were almost similar 
and varied only in their intensity (quantitative markers) 
expect the chemical shift at 5.86 ppm.
In the spheroid culture, we had observed several quali-
tative chemical shift markers for both primary and meta-
static melanoma spheroids. Eight (3.58, 3.60, 3.67, 3.75, 
4.12, 4.39, 6.16, 8.07  ppm) chemical shift markers were 
observed in the primary melanoma spheroids and one 
marker namely 8.25 ppm for metastatic melanoma sphe-
roids (Fig. 2; Table 1).
Melanoma cells were observed to behave differently 
with different cell culture methods. In this analysis, we 
identified the chemical shifts that were unique to the cell 
line by excluding the chemical shifts that were specific 
to the cell culture method, irrespective of the cell lines. 
Comparison of primary melanoma cells cultured as mon-
olayer and as spheroid yields five chemical shift markers 
(1.16, 2.71, 2.74, 3.04, 3.25 ppm) for primary melanoma 
cells cultured as monolayer and 10 chemical shift mark-
ers (2.19, 2.72, 2.93, 3.58, 3.61, 4.02, 4.12, 4.39, 6.07, 












Fig. 1 Experimental design
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Similarly, in the case of metastatic melanoma cells, 
three chemical shift markers (3.08, 3.72–3.75, 3.90 ppm) 
were observed for metastatic melanoma cells cultured as 
monolayer and two (3.19 and 3.48  ppm) chemical shift 
markers were observed in metastatic melanoma cells cul-
tured as spheroids (Fig. 4; Table 1).
In this study, we also intend to identify chemical shift 
markers with respect to the culturing method irrespec-
tive of the type of cell line. We were able to identify four 
chemical shift markers (2.85, 3.22, 3.96, 5.29 ppm) found 
only in the cells grown as monolayer and 10 chemical 
shift markers (2.72, 3.63, 3.66, 3.78, 4.05, 4.21, 4.32, 7.12, 
7.44, 7.83 ppm) found specific to the cells grown as sphe-
roids (Table 1).
Partial least square-discriminant analysis (PLS-DA) 
and clustering analysis performed between the primary 
and metastatic cells showed that culturing method had a 
more dominant influence over their 1H NMR spectrum 
than the cell line differences (Fig. 5).
Discussions
Guanosine as the biomarker for primary melanoma 
in monolayer culture
This chemical shift 5.86, which was unique to the pri-
mary melanoma cells cultured as monolayer is assigned 
to guanosine, which is the integral part of the cGMP, an 
important second messenger in various intra-cellular 
signal transduction pathways. This suggests that under 
monolayer culture, guanosine is the biomarker of pri-
mary melanoma cells (WM115).
Primary melanoma spheroids and metastatic spheroids 
vary in glucose accumulation and phospholipid 
composition
The identified chemical shift markers of primary mel-
anoma spheroids were assigned to threonine (3.58, 
3.60  ppm), glucose (3.67, 6.16  ppm), glycerol-phos-
phoethanolamine (4.12  ppm) N-acetyl-galactosaminitol 
(4.39  ppm) and NH2 proton (8.07  ppm) (Table  1). The 
chemical shift marker of the metastatic melanoma sphe-
roids was assigned to ATP (8.25  ppm). The primary 
melanoma spheroids suggest the presence of amino acid 
threonine which could indicate the presence of a mem-
brane protein that was rich in threonine. Threonine 
had been reported in the literature as a biomarker for 
ER (endocrine hormone receptor) positive breast can-
cer [23]. Interestingly primary melanoma spheroids had 
been found to have glucose, a key energy source that was 
not detected in metastatic melanoma spheroids. It had 
been shown that during the detachment of cells from the 
Fig. 2 1D 1H NMR spectra showing the qualitative chemical shift markers; red font qualitative chemical shift markers between WM115 spheroids 
and WM266 spheroids; green font qualitative chemical shift markers between WM115 monolayer and WM266 monolayer; black font–boxed qualita‑
tive chemical shift markers between monolayers and spheroids irrespective of the type of cell lines
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Table 1 List of qualitative chemical shift markers and its chemical shift assignment
S. no Cell line/culture type 1H NMR markers (ppm) Assignment Reference
1 2D Primary melanoma 5.86 (d) Guanosine [21]
2 Metastatic melanoma – – –
3 3D Primary melanoma 3.58 (d) Threonine [22, 23]
3.60 (d) Threonine [24]
3.67 (s) Glucose [23]
3.75 Glutamine
4.12 (t) Glycerophospoethanolamine [25, 26]
4.39 (s) N‑Acetylgalactosaminitol [27]
6.16 (d) Glucose [28]
8.07 (s) NH2 [29]
4 Metastatic melanoma 8.25 (s) ATP [30]
5 Primary melanoma 2D 1.16 (s) Lipids [31]
2.71 (s) Dimethylamine [32]
2.74 (s) Dimethylamine [33]
3.04 Creatine/phosphocreatine [25]
[34, 35]
3.25 (s) Choline head groups of phospholipids [36]
6 3D 2.19 (s) Adipate [37]
2.72 (t) Unassigned
2.93 (s) Dimethyl glycine [26]
3.58 (d) Threonine [23]
3.61 (d) Glycerol [38]
4.02 (s) 2 Hydroxyglutarate [39, 40]
4.12 (t) Glycerophosphoethanolamine [38]
4.39 (s) N‑Acetylgalactosaminitol [27]
6.07 (d) Unassigned
6.17 (s) Unassigned
7 Metastatic melanoma 2D 3.08 Methyl lysine [40]
[41]
3.72–3.75 (q) Unassigned
3.90 (s) Glucose [42]
8 3D 3.19 (s) O‑Acetylcarnitine [37]
3.48 (s) Unassigned
9 2D 2.85 (s) Asparagine [43]
3.22 Choline [25]
3.96 (t) β‑Cyclodextrin [44]
5.29 (s) Hc–ch (l, ch)  [31]
10 3D 2.72 (t) Unassigned




4.05 (t) Ethanolamine [45]
4.21 Phosphocholine [38]
4.32 Glycerophosphocholine [31]
7.12 (s) Ar–H [31]
7.44 (d) Unassigned
7.83 (s) Amide (–NH) [37]
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Fig. 3 1D 1H NMR spectra showing the qualitative chemical shift markers between WM115 monolayer and WM115 spheroids
Fig. 4 1D 1H NMR spectra showing the qualitative chemical shift markers between WM266 monolayer and WM266 spheroids
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extracellular matrix, the cancer cells stopped the glucose 
consumption that resulted in energetic stress. In mela-
noma, it was shown that during metastasis the ROS lev-
els increases dramatically, which could be attributed to 
the cessation in the glucose uptake. When the glucose 
consumption was stopped the ATP production would 
cease, but we observed ATP as the biomarker for meta-
static melanoma, this is because once the ATP level starts 
to decline AMP-activated protein kinase (AMPK) will 
be activated and inhibits fatty acid synthesis and acti-
vate fatty acid oxidation pathway. This shift in the fatty 
acid metabolism resulted in the generation of NADPH 
and promotes the generation of α-ketoglutaric acid 
from isocitric acid, which also increased the NADPH. 
This NADPH which is generated by the AMPK activa-
tion could enter into electron transport chain resulting 
in the synthesis of ATP [46]. N-Acetylgalactosaminitol, 
observed in the primary melanoma spheroids, forms an 
integral part of cancer associated glycoproteins [50].
Differences in the cell culturing method are primarily 
reflected in the phospholipid composition
The comparison of the chemical shifts of the cells cul-
tured as monolayers and cells cultured as spheroids 
irrespective of the cell line differences we could observe 
chemical shift signatures for both monolayer cultures 
as well as the spheroid cultures. The chemical shift sig-
natures of the monolayer cultures were assigned to 
Asparagine (2.85 ppm), choline compounds (3.22 ppm), 
β-cyclodextrin (3.96  ppm), and lipids (5.29  ppm). From 
our data, the presence of lipids and choline compounds, 
which formed the plasma membrane were evident in 
the monolayer cultures as more cellular surface area had 
been exposed compared to the cells in the spheroid cul-
ture. The triplet at 3.96 is assigned to β-cyclodextrin, but 
the biological origin of this compound is unclear. They 
have a very interesting property of forming inclusion 
complexes with various lipophilic compounds [44].
On the other-hand the chemical shift signatures of the 
spheroids were assigned to glycerol (3.63 and 3.66 ppm), 
inositol (3.66  ppm), phosphoinositol (3.78  ppm), ethan-
olamine (4.05  ppm), phosphocholine (4.21  ppm), glyc-
erophosphocholine (4.32  ppm) and amide group (–NH) 
(7.83 ppm). The presence of glycerol, inositol, ethanola-
mine, phosphocholine and glycerophosphocholine shows 
the existence of the glycerophospholipids, the key com-
ponent of cell membrane suggests that the multicellular 
spheroids closely resembles the cells in vivo.
Fig. 5 a Dendrogram showing distinct clusters of primary and metastatic melanoma cells cultured as monolayer and spheroids. This shows the 
impact of the cell culturing method. b PLS‑DA plot showing the variance between the primary (PM) and metastatic melanoma (MM) cells cultured 
as monolayer and spheroids
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Differences in the culturing method is reflected in the 
phospholipid of primary melanoma cells
Primary melanoma cells showed differences in their 
behavior with respect to the culturing method. The 
markers of primary melanoma cultured as monolayer 
were assigned to lipids (1.16, 5.29 ppm), dimethylamine 
(2.71, 2.74  ppm), phosphocreatine (3.04  ppm) and cho-
line head groups of phospholipids (3.25  ppm). Thus 
primary melanoma cells in monolayer produce certain 
common cell membrane components like choline and 
lipids. They also contain phosphocreatine a key reserve 
for the high energy phosphates, which could be utilized 
for the formation of ATP. Dimethylamine could be the 
result of l-citrulline formation from asymmetric dime-
thyl arginine (ADMA) [48].
On the other-hand when these same primary mela-
noma cells were cultured as spheroids they produce some 
unique chemical shift signatures that could be assigned 
to adipate (2.19 ppm), dimethyl glycine (2.93 ppm), thre-
onine (3.58 ppm), glycerol (3.61 ppm), 2-hydroxy glutar-
ate (4.02 ppm), glycerophosphoethanolamine (4.12 ppm), 
N-acetylgalactosaminitol (4.39 ppm). Adipate is an acid-
ity regulator, which plays a vital role in maintaining the 
acidity balance in the cellular microenvironment. This 
acidity regulation is very important as the cells would 
produce lactate as a result of their metabolic activity. 
Glycerol and glycerophosphoethanolamine were the 
integral components of the phospholipids in the cell 
membrane. This suggests that the 3D architecture of the 
multicellular spheroids of the metastatic melanoma cells 
vary from their monolayer counterpart primarily in the 
plasma membrane composition. 2-Hydroxy glutarate 
(2-HG) is a well known as oncometabolite which will 
usually accumulate in malignant cells due to the gain of 
function mutation of the isocitric dehydrogenases (IDH). 
Accumulation of the 2-HG inhibits the 2-oxo glutar-
ate dependent oxygenases which in turn inhibits histone 
lysine demethylases thus impairing the epigenetic modi-
fications of histones [49, 50]. This proves the closeness 
of the 3D spheroids with the in  vivo tissues. Previous 
studies on the rectal adenocarcinoma had shown that 
N-acetylgalactosaminitol forms an integral part in all the 
four oligosaccharides isolated from the mucin-like glyco-
protein of rectal adenocarcinoma. Clearly, N-acetylgalac-
tosaminitol involves in the formation of cancer associated 
glycoproteins [47].
Glucose accumulation and O‑acetyl carnitine mark the 
differences between the metastatic melanoma cells 
cultured as monolayer and as spheroids
Variations in the chemical shift signatures with 
respect to the culturing method was also observed in 
the metastatic melanoma cells. The chemicals shifts 
of the monolayer cultured cells suggested the pres-
ence of methyl lysine (3.08  ppm), glucose (3.90  ppm), 
and whereas the chemical shifts of metastatic mela-
noma spheroids revealed the presence of O-acetyl 
carnitine (3.19  ppm). This data showed that methyl 
lysine and glucose resonating at 3.08 and 3.90  ppm 
respectively were the qualitative markers for the meta-
static melanoma cells cultured as monolayer but the 
same cell line when cultured as spheroids they don’t 
produce chemical shift peaks at 3.08 and 3.90  ppm 
instead they produce a chemical shift at 3.19 which 
is assigned to O-acetyl carnitine. The chemical shift 
at 3.08 is attributed to proton from the CH2 group of 
the methyl lysine. Although it is previously reported 
that, this chemical shift manifested the presence of 
the SH2 group in taurine [51, 52]. In these studies, the 
3.08 ppm chemical shift has appeared as a triplet, but in 
our data, the 3.08 ppm appear as a singlet. In a previous 
report, where the chromatin core particles where ana-
lyzed using proton nuclear magnetic resonance spec-
trometry encountered the 3.08  ppm chemical shift as 
a singlet, and it was assigned to the CH2 group proton 
of the methyl lysine [41]. Methylated amino acids espe-
cially methyl-lysine and methyl-arginine in the chroma-
tin plays a vital role in recruiting proteins that induce 
structural changes in chromatin thus influencing gene 
expression and repression [53].
Clinical projections of this study
In this study, we used the 3D spheroids, in order to mini-
mize the limitations in its clinical translation. Flat mon-
olayer cultures were the simplistic cancer models, having 
a physiologically uniform environment and lacked in the 
cell to cell attachment, which is not the case in the actual 
tumor environment. In in  vivo tumors there exists cell 
to cell attachment, oxygen gradient, nutrition gradient 
and waste gradient. This behavior can be reproduced by 
culturing cells as 3D spheroids [54]. 2D flat monolayer 
cultured cells showed apical–basal polarity and lacks his-
tological differentiation of the in  vivo tumors, whereas 
histological morphology similar to the in vivo tumor can 
be achieved in 3D spheroids. [55, 56]. Like the in  vivo 
tumors, 3D spheroids exhibit phenotypic heterogeneity 
in the cell proliferation rate, gene expression and differ-
entiation which led to the heterogeneity in the function 
and morphology [57]. Few cells exhibited the stem cell-
like characteristics such as self-renewal and undifferen-
tiated multipotent phenotype called cancer stem cells 
(CSCs) [58]. These CSCs were observed in both in vitro 
3D tumor spheroids and in  vivo tumors [59], and these 
stemness related genes were found to be upregulated in 
3D spheroids compared to the 2D monolayers [60]. All 
the above studies showed the cells grown as 3D spheroids 
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resemble closely to the cells in the in vivo tumors. Thus, 
we expect there won’t be any potential limitations in 
the clinical translation of the results of this study and of 
course an actual clinical translational study is necessary 
to corroborate this statement.
Conclusion
In this study, we showed that the two closely associated 
cell lines, which were obtained from the same donor and 
differed only in the stages of melanoma could be identi-
fied as different cell lines by employing 1D 1H NMR spec-
trometry. Thus proving the specificity of this method in 
characterizing cancer cell lines. Our study suggests that 
the glucose accumulation and phospholipid composi-
tion vary significantly between the primary and meta-
static cells lines that were obtained from a single donor 
and also with the cell culturing methods. These results 
encourage further researches on understanding the 
effects of phospholipid and glucose accumulation in can-
cer development, progression and invasion. This study 
also showed that the method of cell culture would dras-
tically affect the phospholipid composition of the cells 
and also depicts that the cells in spheroid culture closely 
resembled the cells in vivo.
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